Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer

Overview of attention for article published in Breast Cancer Research and Treatment, October 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 3 news outlets

twitter: 3 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 28 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

New substance could improve efficacy of established breast cancer treatments

The Medical News, 13 Dec 2018

Physicians from Karl Landsteiner University of Health Sciences in Krems (Austria) demonstrate potential for clinical application…

BREAST CANCER: NEW COMPOUND COULD ENHANCE THE EFFICACY OF STANDARD TREATMENT

Biospace, 12 Dec 2018

Physician-scientists from the Karl Landsteiner University of Health Sciences, Krems (Austria) together with colleagues from…

New compound could enhance the efficacy of standard breast cancer treatment

MedicalXpress, 12 Dec 2018

A novel compound against breast cancer improves the efficacy of standard cancer treatment and shows superior tolerability in…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.